Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ono Pharmaceutical Co. Ltd.
DescriptionPG receptor (EP2/EP3) agonist
Molecular Target Prostaglandin E2 (PGE2) receptor EP3 subtype (Prostanoid EP3 receptor) (PTGER3)
Mechanism of ActionProstaglandin E2 (PGE2) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Genitourinary (unspecified)
Indication DetailsTreat underactive bladder
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today